Nanoparticles as novel therapeutic agents
This project aims to explore potential therapeutic applications of nanoparticles through advanced particle design and surface modification.
Major achievements
Preliminary studies on the cytotoxicity and reactive oxygen scavenging properties of nanoparticles on mammalian cell lines have been completed.
Future plans and directions
Engineering of nanoparticles and surface modification for the purpose of targeted delivery.
Collaborators
Dr Megan Lord, Graduate School of Biomedical Engineering, The University of New South Wales
